These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27046239)

  • 21. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.
    Nice TJ; Baldridge MT; McCune BT; Norman JM; Lazear HM; Artyomov M; Diamond MS; Virgin HW
    Science; 2015 Jan; 347(6219):269-73. PubMed ID: 25431489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis.
    Richardson C; Bargatze RF; Goodwin R; Mendelman PM
    Expert Rev Vaccines; 2013 Feb; 12(2):155-67. PubMed ID: 23414407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a proteinaceous cellular receptor for a norovirus.
    Orchard RC; Wilen CB; Doench JG; Baldridge MT; McCune BT; Lee YC; Lee S; Pruett-Miller SM; Nelson CA; Fremont DH; Virgin HW
    Science; 2016 Aug; 353(6302):933-6. PubMed ID: 27540007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.
    Tan M; Jiang X
    Nanomedicine (Lond); 2012 Jun; 7(6):889-97. PubMed ID: 22734641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of norovirus infection.
    O'Brien SJ; Sanderson RA; Rushton SP
    Curr Opin Gastroenterol; 2019 Jan; 35(1):14-19. PubMed ID: 30346315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral shape-shifting: norovirus evasion of the human immune system.
    Donaldson EF; Lindesmith LC; Lobue AD; Baric RS
    Nat Rev Microbiol; 2010 Mar; 8(3):231-41. PubMed ID: 20125087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norovirus encounters in the gut: multifaceted interactions and disease outcomes.
    Hassan E; Baldridge MT
    Mucosal Immunol; 2019 Nov; 12(6):1259-1267. PubMed ID: 31501514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Norovirus: Experimental Models of Infection.
    Todd KV; Tripp RA
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30759780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus.
    Liu G; Kahan SM; Jia Y; Karst SM
    J Virol; 2009 Jul; 83(13):6963-8. PubMed ID: 19403675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations.
    Donaldson EF; Lindesmith LC; Lobue AD; Baric RS
    Immunol Rev; 2008 Oct; 225():190-211. PubMed ID: 18837783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Akt Plays Differential Roles during the Life Cycles of Acute and Persistent Murine Norovirus Strains in Macrophages.
    Owusu IA; Passalacqua KD; Mirabelli C; Lu J; Young VL; Hosmillo M; Quaye O; Goodfellow I; Ward VK; Wobus CE
    J Virol; 2022 Feb; 96(3):e0192321. PubMed ID: 34787460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in understanding of the innate immune response to human norovirus infection using organoid models.
    Mboko WP; Chhabra P; Valcarce MD; Costantini V; Vinjé J
    J Gen Virol; 2022 Jan; 103(1):. PubMed ID: 35077345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in understanding norovirus pathogenesis.
    Karst SM; Tibbetts SA
    J Med Virol; 2016 Nov; 88(11):1837-43. PubMed ID: 27110852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New interventions against human norovirus: progress, opportunities, and challenges.
    Li J; Predmore A; Divers E; Lou F
    Annu Rev Food Sci Technol; 2012; 3():331-52. PubMed ID: 22385167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine against norovirus.
    Tan M; Jiang X
    Hum Vaccin Immunother; 2014; 10(6):1449-56. PubMed ID: 24718366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.
    Ghosh S; Malik YS; Kobayashi N
    Curr Drug Metab; 2018; 19(3):170-191. PubMed ID: 28901254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin A modifies the intestinal chemokine and cytokine responses to norovirus infection in Mexican children.
    Long KZ; Garcia C; Ko G; Santos JI; Al Mamun A; Rosado JL; DuPont HL; Nathakumar N
    J Nutr; 2011 May; 141(5):957-63. PubMed ID: 21411606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.
    Blazevic V; Lappalainen S; Nurminen K; Huhti L; Vesikari T
    Vaccine; 2011 Oct; 29(45):8126-33. PubMed ID: 21854823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycolysis Is an Intrinsic Factor for Optimal Replication of a Norovirus.
    Passalacqua KD; Lu J; Goodfellow I; Kolawole AO; Arche JR; Maddox RJ; Carnahan KE; O'Riordan MXD; Wobus CE
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights into the global burden of noroviruses and opportunities for prevention.
    Hall AJ; Glass RI; Parashar UD
    Expert Rev Vaccines; 2016 Aug; 15(8):949-51. PubMed ID: 27142965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.